Log In
BCIQ
Print this Print this
 

CM-182

  Manage Alerts
Collapse Summary General Information
Company Curemark LLC
DescriptionUndisclosed biologic
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat amphetamine-induced hyperactivity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today